Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis
The pharmacokinetic (PK) studies of meropenem in Chinese newborns with late-onset sepsis (LOS) are still lacking. Causative pathogens of LOS and their susceptibility patterns in China differ from the data abroad. We, therefore, conducted a developmental population pharmacokinetic-pharmacodynamic ana...
Saved in:
Main Authors: | Yue-E Wu (Author), Chen Kou (Author), Xue Li (Author), Bo-Hao Tang (Author), Bu-Fan Yao (Author), Guo-Xiang Hao (Author), Yi Zheng (Author), John van den Anker (Author), Dian-Ping You (Author), A-Dong Shen (Author), Wei Zhao (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
by: Zhen-Hai Shang, et al.
Published: (2022) -
Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients
by: Abdullah Alsultan, et al.
Published: (2024) -
Physiologically based pharmacokinetic-pharmacodynamic evaluation of meropenem in CKD and hemodialysis individuals
by: Guoliang Deng, et al.
Published: (2023) -
Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
by: Sonia Luque, et al.
Published: (2021) -
Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
by: Yang Zhao, et al.
Published: (2020)